Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer
Θεοδώρα Κάτσιλα(National Hellenic Research Foundation), Josep Villanueva(Memorial Sloan Kettering Cancer Center)
Cited by 25
Related Papers
Differential exoprotease activities confer tumor-specific serum peptidome patterns
|Journal of Clinical Investigation|2005|748
Clinical implementation of preemptive pharmacogenomics in psychiatry
|EBioMedicine|2024|56
Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes
|Cancer Discovery|2025|7